Distinct subtypes of triple negative (TN) breast cancer have been identified by tumor expression profiling. However, little is known about the relationship between histopathologic features of TN tumors, which reflect aspects of both tumor behavior and tumor microenvironment, and molecular TN subtypes. The histopathologic features of TN tumors were assessed by central review and 593 TN tumors were subjected to whole genome expression profiling using the Illumina Whole Genome DASL array. TN molecular subtypes were defined based on gene expression data associated with histopathologic features of TN tumors. Gene expression analysis yielded signatures for four TN subtypes (basal-like, androgen receptor positive, immune, and stromal) consistent w...
In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are ass...
Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern th...
International audienceIn patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymp...
Distinct subtypes of triple negative (TN) breast cancer have been identified by tumor expression pro...
Breast cancer is a heterogeneous disease usually including four molecular subtypes such as luminal A...
Breast cancer is a heterogeneous disease usually including four molecular subtypes such as luminal A...
Triple negative breast cancer (TNBC) lacks well-defined molecular targets and is highly heterogenous...
Background: Triple-negative breast cancer (TNBC) accounts for 12–20% of all breast cancers. Diagnosi...
Introduction: Current prognostic gene expression profiles for breast cancer mainly reflect prolifera...
Background Gene expression profiling has been used to define molecular phenotypes of...
Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern th...
International audienceINTRODUCTION: Triple-negative breast cancers need to be refined in order to id...
Aims and background. We evaluated the difference in and significance of cancer cell metabolism by mo...
Background: Heterogeneity and lack of targeted therapies represent the two main impediments to preci...
Breast cancers can be divided into subtypes with important implications for prognosis and treatment....
In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are ass...
Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern th...
International audienceIn patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymp...
Distinct subtypes of triple negative (TN) breast cancer have been identified by tumor expression pro...
Breast cancer is a heterogeneous disease usually including four molecular subtypes such as luminal A...
Breast cancer is a heterogeneous disease usually including four molecular subtypes such as luminal A...
Triple negative breast cancer (TNBC) lacks well-defined molecular targets and is highly heterogenous...
Background: Triple-negative breast cancer (TNBC) accounts for 12–20% of all breast cancers. Diagnosi...
Introduction: Current prognostic gene expression profiles for breast cancer mainly reflect prolifera...
Background Gene expression profiling has been used to define molecular phenotypes of...
Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern th...
International audienceINTRODUCTION: Triple-negative breast cancers need to be refined in order to id...
Aims and background. We evaluated the difference in and significance of cancer cell metabolism by mo...
Background: Heterogeneity and lack of targeted therapies represent the two main impediments to preci...
Breast cancers can be divided into subtypes with important implications for prognosis and treatment....
In patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are ass...
Greater understanding of the biology of triple-negative breast cancer (TNBC) is needed to discern th...
International audienceIn patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymp...